The form of Charcot-Marie-Tooth type 4B (CMT4B) disease caused by mutations in myotubularin-related 5 (MTMR5; also called SET Binding Factor 1; SBF1) shows a spectrum of axonal and demyelinating nerve phenotypes. This contrasts with the CMT4B subtypes caused by MTMR2 or MTMR13 (SBF2) mutations, which are characterized by myelin outfoldings and classic demyelination. Thus, it is unclear whether MTMR5 plays an analogous or distinct role from that of its homolog, MTMR13, in the peripheral nervous system (PNS). MTMR5 and MTMR13 are pseudophosphatases predicted to regulate endosomal trafficking by activating Rab GTPases and binding to the phosphoinositide 3-phosphatase MTMR2. In the mouse PNS, Mtmr2 was required to maintain wild type levels of Mtmr5 and Mtmr13, suggesting that these factors function in discrete protein complexes. Genetic elimination of both Mtmr5 and Mtmr13 in mice led to perinatal lethality, indicating that the two proteins have partially redundant functions during embryogenesis. Loss of Mtmr5 in mice did not cause CMT4B-like myelin outfoldings.
INTRODUCTION
outfoldings analogous to those observed in the nerves of CMT4B1 (MTMR2) and CMT4B2 (MTMR13) patients.
To elucidate the role of Mtmr5 in the PNS, we generated an Mtmr5 knockout mouse model using CRISPR-Cas9 gene editing, and subsequently assessed the pathological consequences of the loss of Mtmr5 on peripheral nerves. We used biochemical approaches to determine how the three CMT-causing Mtmr proteins physically interact, and inferred how these interactions may relate to the observed nerve phenotypes. Our study indicates that the homologous proteins, Mtmr5 and Mtmr13, both require Mtmr2 to maintain wild type levels of protein abundance in the PNS, but each play distinct roles during axon radial sorting and myelination.
RESULTS

A novel deletion allele of Mtmr5
Initial characterization of an Mtmr5 deletion allele in mice was described prior to the discovery that mutations in human MTMR5 cause CMT4B3 disease (31). The previously described Mtmr5 deletion causes male infertility, but whether these mice develop peripheral nerve defects was not examined (31). We attempted to reestablish this mouse line using intracytoplasmic sperm injection, but were unsuccessful. Therefore, an Mtmr5 deletion allele was generated using CRISPR-Cas9 mutagenesis and subsequently assessed for nerve defects.
To target Mtmr5, guide RNAs (gRNAs) were designed to target exon 1 and exon 25 ( Fig. 2A ).
Founder mice were screened for mutations in exon 1 and/or large deletions that removed the sequences between exon 1 and exon 25. A founder mouse was determined to be mosaic for two distinct fusions of exon 1 and exon 25 (mutation 1 and 2) ( Fig. 2A ). Only mutation 2 was passed to progeny mice (Fig. 2B ). This novel Mtmr5 mutation is predicted to yield a frame-shift that leads to a premature stop codon in exon 25; translation would result in a non-functional six amino acid peptide ( Fig. 2A; Supp. Fig. S1 ).
Consistent with the predicted gene disruption, the full-length 208 kDa Mtmr5 protein was undetectable in sciatic nerve and brain exacts from adult Mtmr5 -/mice ( Fig. 2C, D) . However, a truncated Mtmr5 protein of 84.8 kDa was detected at a low level in brain extracts from post-natal day 7 (P7) Mtmr5 -/and Mtmr5 +/mice (Supp. Fig. S2 ). We predict that translational initiation at an ATG codon in exon 26 leads to low-level expression of this truncated Mtmr5 protein, at least in neonatal mouse brains. The described, N-terminally truncated Mtmr5 protein was not detected in adult brain or sciatic nerve extracts (Supp. Fig. S2 ). When expressed, the truncated protein may be non-functional, as it lacks both the DENN and PH-GRAM domains (Fig. 1 ).
Mtmr5 -/mice were viable and observed at the frequency predicted by Mendelian genetics. Homozygous mutants of both sexes were about 30% smaller than wild type and Mtmr5 +/controls (Supp. Fig. S3 ). This weight difference was observed at weaning and continued throughout the life of the animal. Overt motor or gait deficiencies were not observed in Mtmr5 -/mice examined at P38 and 17 months (data not shown). Mtmr5 -/males were sterile (Table 1) , consistent with previous observations made using a distinct deletion allele (31). The absence of Mtmr5 protein expression, and the sterility of Mtmr5 -/males strongly suggests that the mutation described here is a null or strongly hypermorphic allele.
Biochemical relationships amongst CMT-linked myotubularins
MTMR5 and MTMR13 are both known to bind avidly to MTMR2 in a manner that requires coiled-coil sequences (26, 32). However, it is unclear whether the pseudophosphatases also interact with each other. To test their physical associations, we overexpressed epitope-tagged MTMR5 with MTMR13 and/or MTMR2 in HEK293 cells. MTMR5 and MTMR13 formed a very weak interaction that did not require coiled-coil dimerization, or their mutual binding partner MTMR2 ( Fig. 3A-C) . The weak interaction between MTMR5 and MTMR13 did not enhance either proteins abundance. In contrast, co-expression of MTMR2 greatly increased the levels of both MTMR5 and MTMR13 (Fig. 3A, B ). These data suggest that MTMR5 and MTMR13 may form a very weak association that does not equate to their avid binding of MTMR2.
We previously demonstrated that Mtmr2 and Mtmr13 require each other to maintain wild type protein levels in mouse sciatic nerves (22). To determine if Mtmr2 and/or Mtmr13 proteins were required to regulate Mtmr5 levels, we examined mutant mouse brain and sciatic nerve lysates. Both Mtmr5 and Mtmr13 protein levels were significantly reduced in Mtmr2 -/nerves ( Fig. 4A, B ). However, the requirement of Mtmr2 to maintain Mtmr5 at wild type levels was not reciprocal; Mtmr5 -/sciatic nerve lysates had comparable Mtmr2 levels to wild type nerves ( Fig.   4D , E). Mtmr13 loss had no impact on Mtmr5 levels in mouse brain or sciatic nerves, demonstrating that these pseudophosphatases do not require one another to maintain wild type protein levels ( Fig. 4A, C) .
The stabilization of Mtmr5/13 by Mtmr2 was unique to the PNS; loss of Mtmr2 had no impact on the levels of Mtmr5 or Mtmr13 in brain extracts (Fig. 4C ). In addition, loss of both Mtmr5 and Mtmr13 in Mtmr5 -/-; Mtmr13 -/mouse embryonic fibroblasts (MEFs) did not impact Mtmr2 abundance (Fig. 4F, G) . In summary, these data demonstrate that Mtmr2 is needed for wild type levels of both Mtmr5 and Mtmr13 protein abundance, specifically in the PNS, where CMT disease manifests.
Reduced sciatic nerve axons and normal myelination in the absence of Mtmr5
In mice, the nerve pathology caused by the loss of Mtmr13 is well-characterized (33, 34).
In contrast, the mouse nerve pathology associated with the loss of Mtmr5 is undefined. Loss-offunction mutations in MTMR13/Mtmr13 cause distinct Schwann cell myelin abnormalities known as myelin outfoldings in both CMT patients and mouse models (33-35). The role of MTMR5 in the PNS remains unclear; significantly different pathology has been described in patient nerve biopsies (18, 27, 28) . Through examination of Mtmr5 -/mouse nerves, we sought to determine whether Mtmr5 has a distinct or analogous role to that of Mtmr13 in the PNS. At 3 months, the morphology of Mtmr5 -/sciatic nerves appeared grossly normal ( Fig. 5A-D) . Loss of Mtmr5 did not cause CMT4B-like myelin outfoldings, indicating a pathology distinct from that caused by the loss of Mtmr13 ( Fig. 5C -E). The absence of Mtmr5 did not alter myelin thickness; g-ratios were not significantly different between Mtmr5 -/and wild type fibers ( Fig. 5F ). However, Mtmr5 -/mice had significantly fewer total myelinated axons in sciatic nerves than wild type controls (Fig. 5G ).
The absence of Mtmr5 did not alter the diameter of myelinated axons, a feature of several mouse models of axonal CMT ( Fig. 5H) (36, 37) . These data demonstrate that Mtmr5 deficiency causes nerve pathology distinct from that caused by the absence of Mtmr13. Thus, despite sharing a common binding partner (Mtmr2), and possessing similar protein structures, the two pseudophosphatases play distinct roles in the murine PNS.
Axonal sorting defects in the absence of Mtmr5
Incomplete radial sorting by immature Schwann cells can lead to the abnormal retention of large caliber axons in bundles, thereby reducing the total number of myelinated axon fibers in nerves (38, 39) . To determine whether the absence of Mtmr5 caused abnormal Remak bundle development, we examined axon bundles of the sciatic nerve area using EM. Wild type and Mtmr5 -/sciatic nerves were characterized by determining the total number of axons per bundle, the proportion of bundled axons whose diameter exceeded 1 μm, and whether bundled axons were incompletely enclosed by Schwann cell processes.
In Mtmr5 -/nerves examined at 3 months, we observed a significant increase in the proportion of bundled axons that had a diameter of >1 μm ( Fig. 6A -C). We also observed a significant increase in single unmyelinated axons, and a decrease in the percentage of bundles containing between 11-20 axons ( Fig. 6D ), suggesting delayed sorting of large axons from bundles, and abnormal retention of such axons in bundles. In addition, bundled axons of Mtmr5 -/nerves were significantly more likely to be incompletely enwrapped by Schwann cell processes, as evidenced by direct contact of axons with basal lamina ( Fig. 6E-H ).
In aggregate, our findings indicate that Mtmr5 regulates late-stage radial sorting of large caliber axons. We propose that, after the completion of radial sorting, Mtmr5 is dispensable for subsequent myelination.
Loss of both Mtmr5 and Mtmr13 is lethal in mice
Mtmr5 and Mtmr13 share 59% protein identity and are the only two proteins in the genome that share their unique set of protein domains ( Fig. 1 ) (40). To assess whether these proteins might have partially redundant functions, we generated Mtmr5 -/-; Mtmr13 -/double knockout (dKO) mice. dKO animals were non-viable, dying during late gestation or within a few hours of birth ( Fig. 7) . Mtmr5 -/-; Mtmr13 -/embryos were observed at the expected Mendelian frequencies at embryonic (E) days 13-15, but were smaller than littermate controls; overt morphological defects were not apparent ( Fig. 7 , Supp. Fig. S4 , and data not shown). In summary, the absence of both Mtmr5 and Mtmr13 leads to physiological deficits that preclude post-natal survival.
Mtmr5 and Mtmr13 have critical roles in the PNS, and both are proposed to activate the early endosomal GTPase Rab21, a regulator of neurite growth and axon guidance (41, 42). Accordingly, we assessed whether the combined loss of both proteins might alter axon guidance and/or peripheral nerve development during embryogenesis. We found that nerve branches in dKO mouse pinna, a region where axon guidance is well defined, appeared morphologically similar to those of controls (Supp. Fig. S4 ). Thus, a strict requirement for Mtmr5 or Mtmr13 for axon guidance appears unlikely.
Myotubularin expression in peripheral nerves and Schwann cells
We considered whether the phenotypic differences between Mtmr5 -/and Mtmr13 -/mice might correlate with the expression levels of the two proteins during PNS development. Mtmr2, Mtmr5, and Mtmr13 protein levels in sciatic nerves were therefore evaluated at distinct time points during mouse development ( Fig. 8A, B ). Mtmr5 levels were highest between P0 and P7, but decreased sharply by P21 ( Fig. 8A, B ). In contrast, Mtmr13 levels increased between P0 and P7, peaked at P21, and decreased moderately thereafter ( Fig. 8A, B ). Mtmr2 protein levels remained relatively constant throughout sciatic nerve development ( Fig. 8A, B ). Thus, Mtmr5 levels were highest during late stage radial sorting (E17-P10), consistent with our morphological findings indicating a role for the protein in this process. In contrast, Mtmr13 protein expression correlated with initial myelination (P0-P14), and, to a lesser degree, with myelin maintenance in adulthood.
We also evaluated the mRNA levels of all 14 myotubularin family members in adult mouse Schwann cells by analyzing a publicly available RNA-Seq dataset (43) . This analysis indicated that Mtmr2 and Mtmr13 are expressed at significantly higher levels than nearly all other Mtmr mRNAs in the Schwann cells of adult nerves ( Fig. 8C ). Mtmr5 mRNA was present at low levels, consistent with our protein expression findings ( Fig. 8A-C) . The observed temporal differences in the expression of Mtmr5 and Mtmr13 correlate with the distinct PNS phenotypes of Mtmr5 -/and Mtmr13 -/mice.
DISCUSSION
Mtmr5-deficient mice as a model CMT disease
Loss of Mtmr5 in mice caused a ~10% reduction in the number of myelinated axons in the sciatic nerve due to radial sorting defects. Several patient families with loss-of-function mutations in MTMR5 show moderate depletion of myelinated axons without defects in myelin structure, suggesting primary axonal neuropathy (28, 29). Given the findings presented here, we propose that abnormal axon radial sorting be considered as a potential primary defect in CMT associated with MTMR5 loss-of-function. The effects of MTMR5 loss-of-function may be exacerbated in humans relative to mice, potentially explaining the greater reductions in myelinated axon numbers observed in patients (28, 29) . Although the precise cause of this feature is unclear, several mouse models of axonal CMT have shown phenotypes milder than their corresponding human conditions (36, (44) (45) (46) (47) (48) . Incomplete radial sorting can be caused by defects in both axons and Schwann cells (1, 49) . Accordingly, future studies employing conditional Mtmr5 knockout alleles will be needed to determine if Mtmr5's role is restricted to axons or Schwann cells.
In the Mtmr5 -/-PNS, myelin was of normal thickness and structure, and notably lacked the distinctive myelin outfoldings caused by the absence of Mtmr2 or Mtmr13. Nerve biopsies from a family of CMT patients with compound heterozygous mutations in MTMR5 (M417V and T1590A) showed CMT4B-like myelin outfoldings (18) ( Fig. 1 ). Our study demonstrates that a null-type mutation in Mtmr5 does not provoke CMT4B-like myelin outfoldings in mice.
Therefore, we speculate that the M417V and T1590A mutations in MTMR5 may trigger CMT in a manner distinct from that caused by MTMR5 elimination (18). One possible mechanism for such an affect might be that mutations M417V and/or T1590A alter MTMR5 in a manner that changes the pseudophosphatase's interaction with its binding partner MTMR2. If a mutated MTMR5 protein were to impair MTMR2 function, myelin outfoldings might be predicted to result.
Mtmr5 and Mtmr13 form distinct protein complexes with Mtmr2 in the PNS
Both Mtmr5 and Mtmr13 levels were enhanced when the proteins were expressed with their binding partner Mtmr2; this effect was observed both in vitro and in the PNS. We showed that Mtmr5 and Mtmr13 form a very weak interaction that was independent of Mtmr2. If extant, 
Control of endosome trafficking by Mtmr5 and Mtmr13 during axon sorting and myelination
A majority of the molecularly-defined forms of demyelinating CMT are caused by mutations in endosomal regulatory proteins (12). Schwann cells select large axons for myelination by integrating signals from ErbB2/3 tyrosine kinase receptors on their cell surfaces (50) (51) (52) . Abnormal trafficking of the ErbB2/3 receptor complex in Schwann cells has been proposed as a common mechanism linking multiple demyelinating subtypes of CMT (16). Our previous work, and that of others has suggested that appropriate regulation of endosomal PI3P levels in Schwann cells is critical to controlling ErbB2/3 trafficking, and the associated downstream signaling (9, 24). Specifically, the loss of Mtmr2 has been shown to increase ErbB2/3 activation during initial myelination (24). As both Mtmr5 and Mtmr13 physically associate with Mtmr2, we speculate that loss of either pseudophosphatase may also lead to increased ErbB2/3 activation, likely by altering receptor trafficking through endosomes. Further investigations focused on Mtmr5 and Mtmr13 may serve to clarify the dual role of ErbB2/3 in controlling axon sorting and myelination (53, 54) .
We speculate that Mtmr5 and Mtmr13 might also influence the trafficking of β1-integrin, which binds to laminin 211 in the Schwann cell basal lamina. The trafficking of β1-integrin through early endosomes is controlled by Rab21, which the DENN domain of Mtmr5/13 has been shown to activate (42) . β1-integrin is required for the extension and maintenance of Schwann cell processes around axons; loss of this surface receptor leads to radial sorting defects and delayed myelination in mice (55) . In Mtmr5 -/nerves, we observed an increase in the proportion of unmyelinated axons that were incompletely ensheathed by Schwann cells. We speculate that this defect might be caused by a reduction in β1-integrin on the surface of Mtmr5 -/-Schwann cells, a result of reduced recycling of the receptor from early endosomes. An analogous defect in β1-integrin trafficking has been demonstrated in Mtmr5/13-deficient Drosophila cells (42) . While ErbB2/3 and β1-integrin may presently be the best candidates for the signaling receptors influenced by Mtmr5/13-mediated endosomal trafficking, other yet to be identified surface proteins may also be regulated by these pseudophosphatases.
Understanding how Mtmr5 and Mtmr13 regulate the trafficking of receptors involved in mediating axo-glial interactions and promyelinating signaling will likely be critical to discerning how the loss of these proteins leads to CMT.
In conclusion, we have shown, for the first time, that Mtmr5 positively regulates axon radial sorting in mouse peripheral nerves. This work demonstrates that Mtmr5 plays a biological role district from that of the homologous Mtmr13 protein, the loss of which causes demyelinating CMT4B2 in humans. Our study may inform investigations of the forms of CMT that result from loss-of-function mutations in MTMR5, and may aid in the definition of the cellular mechanisms that underpin this condition.
MATERIALS AND METHODS
Mice
All animal work was approved by and conformed to the standards of the Oregon Health & Science University Animal Care and Use Committee. Mtmr2 -/and Mtmr13 -/mice have been previously described (22, 33 ). An Mtmr5 deletion allele was generated via CRISPR/Cas9 mutagenesis. To do so, two guide RNAs were designed against exon 1 and exon 25 of the mouse Mtmr5 gene using the online tool CRISPR Design. The following guide RNAs (gRNAs) were selected for their minimal off-target affects and potential to generate a large deletion beginning after the start-site (exon 1: GCTCGCGGACTACTTCGTGC) and ending after a cloning and Sanger sequencing. Mice were breed to homozygosity and western blots were run to confirm Mtmr5 protein loss in brain and sciatic nerve tissue. To test male sterility, six Mtmr5 -/male mice were allowed to breed with C57BL/6 females for at least 21 days. Bred females were monitored for pregnancy and births for an additional three to four weeks. chemiluminescent quantitation was performed as previously described (23).
Sciatic Nerve Morphology
Mice were perfused with Karnovsky's EM fixative (4% paraformaldehyde, 2% glutaraldehyde; 0.1 M sodium cacodylate, pH 7.4). Sciatic nerves were dissected and further fixed for at least 24 hours at 4°C. Nerves were washed three times in 0.1 M sodium cacodylate (pH 7.4) and three times in 0.1 M sodium phosphate buffer (PB; pH 7.4) at room temperature (RT). Nerves were subsequently post-fixed and stained in 2% osmium tetraoxide in 0.1 M PB buffer (pH 7.4) for 1 hr. The nerves were then washed three times in 0.1 M PB at RT and underwent a series of ethanol dehydrations (25%, 50%, 70%, 80%, and 95%; 5 min each). A final dehydration was performed by incubating samples twice in 100% EtOH (10 min each), followed by two incubations in propylene oxide (10 min each). Nerves were infiltrated overnight in a 1:1 propylene oxide:Embed 812 resin mixture, and subsequently in freshly-prepared 100% Embed 812 resin. Nerves were embedded in a 60°C oven for 48 h. The distal end was positioned toward the beveled end of the mold to orient the nerves in the same direction.
Toluidine blue-stained semi-thin (200-500 μm) plastic cross-sections were prepared from the mid-sciatic nerve. Four non-overlapping images of nerve sections were acquired at 63x on a Zeiss Axio Imager M2 ApoTome microscope with an AxioCam 512 color camera. The tile feature in Zeiss Zen 2 (blue edition) software was used to capture the entire transverse fascicular area (TFA) of each nerve. To obtain total axon counts, tiled 63x Toluidine bluestained images were used. All myelinated axons in the TFA were marked and counted using Cell Counter plugin for Fiji (58) . G-ratio was determined using the G-ratio plugin for Fiji. 200 myelinated axons were randomly selected across 4 non-overlapping 63x Toluidine blue images of the TFA. To obtain an area-based G-ratio measurement, the area of the axon was divided by the area of the myelinated fiber. This measurement was then used to derive a diameter-based G-ratio measurement.
EM images were obtained using a FEI Tecnai G2 microscope operating at 80 kV and an Advanced Microscopy Techniques camera. To analyze Remak bundles, 2900x EM images were used. All intact Remak axons in the large fascicle of each nerve were analyzed. Each Remak axon was counted, and its area was measured. Any axon with an area greater than 0.79 μm 2 (1 μm in diameter) was considered large. 2900x EM images were also used to count abnormally ensheathed axons. At least 42% of the nerve TFA was exhaustively analyzed for each mouse.
Immunofluorescence
Whole-mount immunofluorescence of E13 mouse embryos with neurofilament medium chain (2H3) antibody was adapted from a published protocol (59) . Individual embryos were stained in microcentrifuge tubes at RT, unless otherwise stated. Embryos were separated from placenta and amnion in 1x PBS, and 3 mm of the tail was removed for use in genotyping. Embryos were 
Statistics
Statistical analyses of immunoblots, weight, and morphology data were performed using a oneway ANOVA followed by a post-hoc Tukey's test when more than two groups were compared. Senderek, J., Bergmann, C., Weber, S., Ketelsen, U.P., Schorle, H., Rudnik-Schoneborn, S., Buttner, R., Buchheim, E. and Zerres, K. 
